Double-stranded RNA sequencing via RNase III E38A digestion followed by HPLC-MS/MS analysis
Open Access
- 25 April 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (7) , 103803
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 16 references indexed in Scilit:
- The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ PerspectiveJournal of Pharmaceutical Sciences, 2022
- Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNAMolecular Therapy Nucleic Acids, 2022
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Purification and characterisation of dsRNA using ion pair reverse phase chromatography and mass spectrometryJournal of Chromatography A, 2017
- Ribonuclease III mechanisms of double‐stranded RNA cleavageWIREs RNA, 2013
- Analysis of native and chemically modified oligonucleotides by tandem ion‐pair reversed‐phase high‐performance liquid chromatography/electrospray ionization mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Crystallographic and Modeling Studies of RNase III Suggest a Mechanism for Double-Stranded RNA CleavageStructure, 2001
- Escherichia coli Ribonuclease III: Affinity Purification of Hexahistidine-Tagged Enzyme and Assays for Substrate Binding and Cleavage2001
- Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopyRNA, 2000
- RNase III cleavage of single-stranded RNA. Effect of ionic strength on the fideltiy of cleavage.Journal of Biological Chemistry, 1976